On the limitation of therapeutic intervention trials in ischemic heart disease: A clinician's viewpoint
- 31 January 1982
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 49 (1) , 252-255
- https://doi.org/10.1016/0002-9149(82)90299-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The FDA's Critique of the Anturane Reinfarction TrialNew England Journal of Medicine, 1980
- The Competing Objectives of Randomized TrialsNew England Journal of Medicine, 1980
- Natural history of left ventricular function during 1 year after acute myocardial infarction: Comparison with clinical, electrocardiographic and biochemical determinationsThe American Journal of Cardiology, 1980
- Clinical judgment and statistics. Lessons from a simulated randomized trial in coronary artery disease.Circulation, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial InfarctionNew England Journal of Medicine, 1977
- Sudden death in the year following myocardial infarctionThe American Journal of Medicine, 1977
- Reduction of Hospital Mortality from Acute Myocardial Infarction by Anticoagulant TherapyNew England Journal of Medicine, 1975
- Anticoagulants in Acute Myocardial InfarctionPublished by American Medical Association (AMA) ,1973
- Assessment of Short-term Anticoagulant Administration after Cardiac InfarctionBMJ, 1969